Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | 0 | 430,440 | 0 | 0 |
| Depreciation Amortization | 0 | 0 | 442,100 | 0 | 0 |
| Other Working Capital | 0 | 0 | 3,360 | 0 | 0 |
| Other Operating Activity | 0 | 0 | -97,910 | 0 | 0 |
| Operating Cash Flow | $0 | $0 | $777,990 | $0 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | -116,250 | 0 | 0 |
| Net Acquisitions | 0 | 0 | -148,990 | 0 | 0 |
| Other Investing Activity | 0 | 0 | -14,230 | 0 | 0 |
| Investing Cash Flow | $0 | $0 | $-279,470 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | -1,082,410 | 0 | 0 |
| Financing Cash Flow | $0 | $0 | $-1,082,410 | $0 | $0 |
| Exchange Rate Effect | 0 | 0 | 680 | 0 | 0 |
| Beginning Cash Position | 0 | 0 | 838,760 | 0 | 0 |
| End Cash Position | 0 | 0 | 255,540 | 0 | 0 |
| Net Cash Flow | $0 | $0 | $-583,210 | $0 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | 0 | 777,990 | 0 | 0 |
| Free Cash Flow | 0 | 0 | 777,990 | 0 | 0 |